CA Patent

CA3055308A1 — Methods of treating cancer

Assigned to Intercept Pharmaceuticals Inc · Expires 2018-09-13 · 8y expired

What this patent protects

The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the invention.

USPTO Abstract

The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the invention.

Drugs covered by this patent

Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc

Patent Metadata

Patent number: CA3055308A1
Jurisdiction: CA
Classification: —
Expires: 2018-09-13
Drug substance claim: No
Drug product claim: No
Assignee: Intercept Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.